Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2010
10/21/2010US20100267006 Method for detection of cirulent strain of influenza type-a virus
10/21/2010US20100266624 Hepatitis-c virus testing
10/21/2010US20100266620 Immunoconjugates for treatment of infectious diseases
10/21/2010US20100266619 Neutralizing Antibodies and Methods of Use Thereof
10/21/2010US20100266618 Compositions and methods for augmenting activity of oncolytic viruses
10/21/2010US20100266617 Antibodies to human programmed death receptor pd-1
10/21/2010US20100266616 Polypeptides, antibody variable domains and antagonists
10/21/2010US20100266614 Ultra high affinity neutralizing antibodies
10/21/2010US20100266613 Anti-tnf-alpha antibodies and their uses
10/21/2010US20100266611 Enhancement of Immune Responses By 4-1BB-Binding Agents
10/21/2010US20100266609 Antibody Molecules Which Bind IL-17A and IL-17F
10/21/2010US20100266606 Antibody therapy for highly pathogenic avian influenza virus
10/21/2010US20100266605 Use of a cd28 binding pharmaceutical substance for making a pharmaceutical composition with dose-dependent effect
10/21/2010US20100266603 Monoclonal Antibody Specific to Ochratoxin A
10/21/2010US20100266601 Antibodies that inhibit tslp activity
10/21/2010US20100266599 Human receptor proteins; related reagents and methods
10/21/2010US20100266598 Peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5
10/21/2010US20100266597 Cytokine receptor zcytor17 multimers
10/21/2010US20100266596 Therapeutic antibody purification method and method of use
10/21/2010US20100266595 Treatment of insulin-resistant disorders
10/21/2010US20100266593 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders
10/21/2010US20100266592 Therapeutic antennapedia-antibody molecules and methods of use thereof
10/21/2010US20100266586 Variable antibodies
10/21/2010US20100266585 Monoclonal Antibodies Specific to Hemagglutinin and Neuraminidase from Influenza Virus H5-Subtype or N1-Subtype and Uses Thereof
10/21/2010US20100266584 Antibodies against the ectodomain of erbb3 and uses thereof
10/21/2010US20100266583 Inhibition of il-17 production
10/21/2010US20100266582 Inhibition of il-17 production
10/21/2010US20100266580 Translocation and mutant tnk1 kinase in human lymphoma
10/21/2010US20100266579 Treatment of inflammatory diseases
10/21/2010US20100266577 Method of Cancer Treatment with Antagonists of FAS Inhibitors
10/21/2010US20100266576 Use of a camelid single-domain antibody for detecting an oligomeric form of an amyloid beta peptide and its applications
10/21/2010US20100266575 SOLUBLE FMS-LIKE TYROSINE KINASE-1 (sFLT-1) ANTIBODY AND RELATED COMPOSITION, KIT, METHODS OF USING, AND MATERIALS AND METHOD FOR MAKING
10/21/2010US20100266542 Receptor coupling agents and therapeutic uses thereof
10/21/2010US20100266533 Death Domain Containing Receptors
10/21/2010US20100266531 Il-17 binding proteins
10/21/2010US20100266530 FcRN ANTIBODIES AND USES THEREOF
10/21/2010US20100266503 Breast Cancer Methods, Medicaments and Agents
10/21/2010US20100266502 Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
10/21/2010US20100266497 Internalizing Anti-CD74 Antibodies and Methods of Use
10/21/2010US20100266494 Treatment of cancer with novel anti-il13 monoclonal antibodies
10/21/2010US20100266493 Agonist antibodies against tshr
10/21/2010US20100266490 Metalloproteinase Binding Proteins
10/21/2010CA2758967A1 New methods of making an antibody and compositions thereof
10/21/2010CA2758964A1 Anti-tnf-.alpha. antibodies and their uses
10/21/2010CA2758751A1 Antibodies against prostate specific membrane antigen
10/21/2010CA2758585A1 B-lymphocyte targeting agents for use in a method for the treatment of a disease
10/21/2010CA2758449A1 Treatment of inflammatory diseases by inhibiting cold-inducible rna-binding protein (cirp)
10/21/2010CA2758438A1 Affinity material
10/21/2010CA2758378A1 Therapeutic antennapedia-antibody molecules and methods of use thereof
10/21/2010CA2757382A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use
10/21/2010CA2756973A1 Use of trifunctional bispecific antibodies for the treatment of tumors associated with cd133+/epcam+cancer stem cells
10/21/2010CA2669470A1 Assay for detecting cathepsin k activity in bone, cartilage and/or soft tissue
10/20/2010EP2241887A2 Diagnostics, drug screening and treatment for cancer
10/20/2010EP2241885A1 Agent and method for diagnosis on the occurrence of alzheimer's disease or the tendency to develop alzheimer's disease
10/20/2010EP2241625A1 Proteinase K resistant surface protein of neisseria meningitidis
10/20/2010EP2241623A2 Monoclonal antibody against a human cytokine receptor
10/20/2010EP2241622A2 Human trk receptors and their derivatives
10/20/2010EP2241578A1 Anti-cldn6 antibody
10/20/2010EP2241577A1 Anti-CD37 antibodies
10/20/2010EP2241576A1 Use of trifunctional bispecific antibodies for the treatment of tumors associated with CD133+/EpCAM+ cancer stem cells
10/20/2010EP2241332A1 Therapeutic agent for pruritus
10/20/2010EP2241331A2 Novel anti-DC-SIGN antibodies
10/20/2010EP2241330A1 Contraceptive methods and compositions related to proteasomal interference
10/20/2010EP2241329A2 Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness
10/20/2010EP2241323A1 Tenascin-W and brain cancers
10/20/2010EP2240517A1 Fdf03 antibodies and uses thereof
10/20/2010EP2240516A1 Methods and agents for improving targeting of cd138 expressing tumor cells
10/20/2010EP2240515A1 Antigen-binding polypeptides against cartilage degeneration
10/20/2010EP2240203A1 Alpha 5 - beta 1 antibodies and their uses
10/20/2010EP2240196A2 Clusterin derived peptide
10/20/2010EP1687338B1 Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses thereof
10/20/2010EP1407269B1 A method for diagnosing a person having multiple sclerosis
10/20/2010EP1366366B1 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
10/20/2010EP0710280B1 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
10/20/2010CN101868478A Inhibition of macrophage-stimulating protein receptor (RON) and methods of treatment thereof
10/20/2010CN101868477A Novel rabbit antibody humanization methods and humanized rabbit antibodies
10/20/2010CN101864447A Construction of prokaryotic expression vector of grass carp reovirus outer capsid protein and preparation method of polyclonal antibody
10/20/2010CN101864398A Monoclonal antibody of anti-gonadotropin-releasing hormone receptor and application thereof
10/20/2010CN101863981A Preparation method of anti-bisphenol A monoclonal antibody
10/20/2010CN101863980A Whole human source anti-vascular endothelial cell growth factor receptor 2 single chain antibody
10/20/2010CN101863979A Monoclonal antibody capable of resisting chlamys farrei particle blood corpuscle and preparation method thereof
10/20/2010CN101863978A Human source anti-rabies virus Fab antibody, cross linking method thereof with nanometer particles and application thereof
10/20/2010CN101863977A J substock lymphoid leuoosis-resistant polyclonal antibody and preparation method thereof
10/20/2010CN101863976A Preparation method of EV71 virus antibody
10/20/2010CN101863975A HBV (Hepatitis B Virus) preS1 B cell epitope peptide, hybridoma cell strain prepared by same and application
10/20/2010CN101863970A Anti-Pf332-DBL region monoclonal antibody capable of restraining invasion of plasmodiumfalciparum
10/19/2010US7816578 produces antibodies comprising two human immunoglobulin loci for use in the treatmnent of cardiovascular, infections, cancer and autoimmune disorders
10/19/2010US7816500 Antibody SACK-1 that binds CD44 glycoforms
10/19/2010US7816499 Antibody that binds histone deacetylase; transcription repressor activity and deacetylate cellular substrates; treatment of cell proliferation disease
10/19/2010US7816498 has a titer in the range of mg/mL meeting requirements for permissible exposure limit (PEL) of toluene, exhibits no cross-reactivity with a carrier protein and exhibits higher competitive inhibition in response to an increasing concentration of hippuric acid; for diagnosing hallucinogenic substances
10/19/2010US7816497 Compositions and methods for inhibiting drusen complement components C3a and C5a for the treatment of age-related macular degeneration
10/19/2010US7816496 Carbonic anhydrase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
10/19/2010US7816493 Carbonic anhydrase for use diagnostic/prognostic tool in detectingf cell proliferative disorders of breast
10/19/2010US7816334 Nucleic acid construct and nucleic acid expression vectors directing expression of a fusion protein consisting of a disease peptide antigen and a first domain of FrC of tetanus toxin; vaccines
10/19/2010US7816319 Methods and products for manipulating uncoupling protein expression
10/19/2010US7816108 producing ethanol by providing a polypeptide having alpha-amylase activity, contacting a starch-comprising composition with the polypeptide to produce a sugar, and fermenting the sugar to produce ethanol
10/19/2010US7816097 Nucleic acid sequence coding Mammastatin; protein useful in diagnosis, therapy fo breast cancer ; antigrowth agents
10/19/2010US7816089 Methods for diagnosing and treating pediatric neoplasms
10/19/2010US7816075 treating a human afflicted with condition characterized by elevated serum triglyceride or very low density lipoprotein (VLDL), comprising the step of administering an inhibitor of human delta-9 stearoyl-CoA desaturase (SCD1) activity; coronary artery disease, Type II diabetes, obesity
10/19/2010US7815916 Using human T cell leukemia virus type III (HTLV-III) RNA to diagnose, treat and prevent infection by human aquired immunodeficiency virus; viricides